Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Novak

Showing results (651-660 of 826) with videos related to

Pageof 83
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 23, 2012
A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 regionJames R Cerhan, Zachary S Fredericksen, Anne J Novak, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 26, 2025
Rational redesign of antigen binding domain improves in vivo efficacy of the CD22-CARKole R DeGolier, Catherine Pham-Danis, Samuel D Burciaga, et al.
The Journal of Experimental Medicine|November 3, 2010
A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signalingJoanne M Hildebrand, Zhenghua Luo, Michelle K Manske, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2008
Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphomaJames R Cerhan, Wen Liu-Mares, Zachary S Fredericksen, et al.
Blood|March 19, 2011
Establishment and characterization of a novel Waldenstrom macroglobulinemia cell line, MWCL-1Lucy S Hodge, Anne J Novak, Deanna M Grote, et al.
Blood Cancer Journal|November 1, 2014
Genetic diversity of newly diagnosed follicular lymphomaY W Asmann, M J Maurer, C Wang, et al.
Scientific Reports|February 22, 2019
Biochar reduces the efficiency of nitrification inhibitor 3,4-dimethylpyrazole phosphate (DMPP) mitigating N<sub>2</sub>O emissionsT Fuertes-Mendizábal, X Huérfano, I Vega-Mas, et al.
Blood|September 12, 2012
t(X;14)(p11;q32) in MALT lymphoma involving GPR34 reveals a role for GPR34 in tumor cell growthStephen M Ansell, Takashi Akasaka, Ellen McPhail, et al.
Blood Cancer Journal|October 11, 2018
Loss of TNFAIP3 enhances MYD88<sub>L265P</sub>-driven signaling in non-Hodgkin lymphomaKerstin Wenzl, Michelle K Manske, Vivekananda Sarangi, et al.
Nature Communications|May 24, 2024
Deleting the mitochondrial respiration negative regulator MCJ enhances the efficacy of CD8<sup>+</sup> T cell adoptive therapies in pre-clinical studiesMeng-Han Wu, Felipe Valenca-Pereira, Francesca Cendali, et al.
Pageof 83

Showing results (651-660 of 826) with videos related to

Sort By:
Pageof 83
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 23, 2012
A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 regionJames R Cerhan, Zachary S Fredericksen, Anne J Novak, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 26, 2025
Rational redesign of antigen binding domain improves in vivo efficacy of the CD22-CARKole R DeGolier, Catherine Pham-Danis, Samuel D Burciaga, et al.
The Journal of Experimental Medicine|November 3, 2010
A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signalingJoanne M Hildebrand, Zhenghua Luo, Michelle K Manske, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2008
Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphomaJames R Cerhan, Wen Liu-Mares, Zachary S Fredericksen, et al.
Blood|March 19, 2011
Establishment and characterization of a novel Waldenstrom macroglobulinemia cell line, MWCL-1Lucy S Hodge, Anne J Novak, Deanna M Grote, et al.
Blood Cancer Journal|November 1, 2014
Genetic diversity of newly diagnosed follicular lymphomaY W Asmann, M J Maurer, C Wang, et al.
Scientific Reports|February 22, 2019
Biochar reduces the efficiency of nitrification inhibitor 3,4-dimethylpyrazole phosphate (DMPP) mitigating N<sub>2</sub>O emissionsT Fuertes-Mendizábal, X Huérfano, I Vega-Mas, et al.
Blood|September 12, 2012
t(X;14)(p11;q32) in MALT lymphoma involving GPR34 reveals a role for GPR34 in tumor cell growthStephen M Ansell, Takashi Akasaka, Ellen McPhail, et al.
Blood Cancer Journal|October 11, 2018
Loss of TNFAIP3 enhances MYD88<sub>L265P</sub>-driven signaling in non-Hodgkin lymphomaKerstin Wenzl, Michelle K Manske, Vivekananda Sarangi, et al.
Nature Communications|May 24, 2024
Deleting the mitochondrial respiration negative regulator MCJ enhances the efficacy of CD8<sup>+</sup> T cell adoptive therapies in pre-clinical studiesMeng-Han Wu, Felipe Valenca-Pereira, Francesca Cendali, et al.
Pageof 83